Treatment patterns and outcomes of patients with relapsed or refractory follicular lymphoma receiving three or more lines of systemic therapy (LEO CReWE): a multicentre cohort study.
Saved in:
| Title: | Treatment patterns and outcomes of patients with relapsed or refractory follicular lymphoma receiving three or more lines of systemic therapy (LEO CReWE): a multicentre cohort study. |
|---|---|
| Authors: | Casulo C; Department of Medicine, Wilmot Cancer Institute, University of Rochester, Rochester, NY, USA. Electronic address: carla_casulo@urmc.rochester.edu., Larson MC; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA., Lunde JJ; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA., Habermann TM; Department of Medicine, Mayo Clinic, Rochester, MN, USA., Lossos IS; Department of Medicine, Comprehensive Sylvester Cancer Center, University of Miami, Miami, FL, USA., Wang Y; Department of Medicine, Mayo Clinic, Rochester, MN, USA., Nastoupil LJ; Department of Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Strouse C; Department of Medicine, University of Iowa, Iowa City, IA, USA., Chihara D; Department of Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Martin P; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Cohen JB; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA., Kahl BS; Department of Medicine, Washington University in St Louis, St Louis, MO, USA., Burack WR; Department of Pathology and Laboratory Medicine, University of Rochester, Rochester, NY, USA., Koff JL; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA., Mun Y; Genentech, South San Francisco, CA, USA., Masaquel A; Genentech, South San Francisco, CA, USA., Wu M; Genentech, South San Francisco, CA, USA., Wei MC; Genentech, South San Francisco, CA, USA., Shewade A; Genentech, South San Francisco, CA, USA., Li J; Genentech, South San Francisco, CA, USA., Cerhan J; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA., Flowers CR; Department of Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Link BK; Department of Medicine, University of Iowa, Iowa City, IA, USA., Maurer MJ; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA. |
| Source: | The Lancet. Haematology [Lancet Haematol] 2022 Apr; Vol. 9 (4), pp. e289-e300. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101643584 Publication Model: Print Cited Medium: Internet ISSN: 2352-3026 (Electronic) Linking ISSN: 23523026 NLM ISO Abbreviation: Lancet Haematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
